Total Payments
$4,517
2024 Payments
$1,206
Companies
49
Transactions
200
Medicare Patients
1,699
Medicare Billing
$174,105
Payment Breakdown by Category
Food & Beverage$3,966 (87.8%)
Education$551.22 (12.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,966 | 191 | 87.8% |
| Education | $551.22 | 9 | 12.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $350.90 | 17 | $0 (2024) |
| Genentech USA, Inc. | $307.55 | 16 | $0 (2024) |
| Janssen Biotech, Inc. | $287.33 | 12 | $0 (2024) |
| Seagen Inc. | $266.65 | 14 | $0 (2023) |
| ABBVIE INC. | $208.03 | 10 | $0 (2024) |
| Amgen Inc. | $194.10 | 5 | $0 (2022) |
| Merck Sharp & Dohme LLC | $185.90 | 10 | $0 (2024) |
| Lilly USA, LLC | $185.07 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $158.44 | 8 | $0 (2024) |
| PFIZER INC. | $150.91 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,206 | 49 | PFIZER INC. ($119.58) |
| 2023 | $970.62 | 41 | Lilly USA, LLC ($133.81) |
| 2022 | $702.99 | 35 | Genentech USA, Inc. ($120.58) |
| 2021 | $277.83 | 16 | Seagen Inc. ($68.93) |
| 2020 | $172.62 | 10 | Novartis Pharmaceuticals Corporation ($38.26) |
| 2019 | $399.85 | 20 | Janssen Biotech, Inc. ($119.21) |
| 2018 | $475.65 | 17 | Pharmacyclics LLC, An AbbVie Company ($115.16) |
| 2017 | $311.66 | 12 | Veran Medical Technologies, Inc. ($118.64) |
All Payment Transactions
200 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Rare Disease | ||||||
| 11/25/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Rare Disease | ||||||
| 11/22/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Oncology | ||||||
| 11/18/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $18.38 | General |
| 11/15/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $25.41 | General |
| Category: Hematology | ||||||
| 10/22/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $17.58 | General |
| Category: Hematology | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Oncology | ||||||
| 10/01/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $0.69 | General |
| Category: ONCOLOGY | ||||||
| 09/14/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2024 | Myriad Genetic Laboratories, Inc. | PRECISETUMOR (Device) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: ONCOLOGY | ||||||
| 08/30/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $33.80 | General |
| Category: ONCOLOGY | ||||||
| 08/23/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/19/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Oncology | ||||||
| 08/02/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.95 | General |
| 07/18/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Oncology | ||||||
| 07/13/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $24.45 | General |
| 06/28/2024 | Genentech USA, Inc. | Kadcyla (Biological), Perjeta, Phesgo | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: BioOncology | ||||||
| 06/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $30.07 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 432 | 756 | $205,216 | $45,073 |
| 2022 | 5 | 419 | 711 | $193,224 | $43,966 |
| 2021 | 6 | 402 | 705 | $188,114 | $42,850 |
| 2020 | 8 | 446 | 783 | $216,420 | $42,216 |
Total Patients
1,699
Total Services
2,955
Medicare Billing
$174,105
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 265 | $83,210 | $18,371 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 185 | 362 | $77,106 | $16,377 | 21.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 65 | 65 | $31,460 | $6,345 | 20.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 44 | 64 | $13,440 | $3,980 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 185 | 337 | $71,781 | $16,479 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 115 | 212 | $66,568 | $14,939 | 22.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 51 | 94 | $19,740 | $5,275 | 26.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $23,716 | $4,508 | 19.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $11,419 | $2,765 | 24.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 197 | 389 | $82,857 | $18,198 | 22.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 108 | 188 | $59,032 | $13,878 | 23.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 51 | 51 | $24,684 | $5,465 | 22.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 48 | $10,080 | $2,574 | 25.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $7,813 | $1,920 | 24.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 16 | $3,648 | $815.70 | 22.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 193 | 383 | $81,579 | $14,247 | 17.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 107 | 222 | $69,708 | $12,803 | 18.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 45 | 76 | $15,960 | $4,454 | 27.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 41 | 41 | $19,844 | $4,099 | 20.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 23 | 23 | $13,823 | $2,927 | 21.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 12 | $7,056 | $1,974 | 28.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 12 | 13 | $5,486 | $1,169 | 21.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 13 | $2,964 | $543.79 | 18.3% |
About Dr. Lijo Simpson, MBBS
Dr. Lijo Simpson, MBBS is a Hematology & Oncology healthcare provider based in Stockbridge, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1134106503.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lijo Simpson, MBBS has received a total of $4,517 in payments from pharmaceutical and medical device companies, with $1,206 received in 2024. These payments were reported across 200 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($3,966).
As a Medicare-enrolled provider, Simpson has provided services to 1,699 Medicare beneficiaries, totaling 2,955 services with total Medicare billing of $174,105. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Stockbridge, GA
- Active Since 12/28/2005
- Last Updated 09/03/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1134106503
Products in Payments
- VENCLEXTA (Drug) $184.26
- KEYTRUDA (Biological) $154.96
- DARZALEX (Biological) $141.66
- IMBRUVICA (Drug) $135.88
- VERZENIO (Drug) $133.81
- Spin (Device) $118.64
- Imbruvica (Drug) $115.16
- ADCETRIS (Biological) $111.66
- ULTOMIRIS (Biological) $110.46
- PADCEV (Biological) $106.68
- Padcev (Drug) $103.22
- LIBTAYO (Biological) $99.11
- LYNPARZA (Drug) $97.84
- BRAFTOVI (Drug) $83.10
- PLUVICTO (Drug) $81.21
- VENASEAL (Device) $74.20
- IBRANCE (Drug) $73.36
- PRECISETUMOR (Device) $71.16
- Enhertu (Drug) $69.93
- MEKINIST (Drug) $67.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Stockbridge
Dr. Jorge Spinolo, Md, MD
Hematology & Oncology — Payments: $22,986
Hematology & Oncology $22,986
Gurinderjit Kaur Sidhu, Md, MD
Hematology & Oncology — Payments: $5,967
Hematology & Oncology $5,967
Dr. Anthony Onyegbula, D.o, D.O
Hematology & Oncology — Payments: $4,685
Hematology & Oncology $4,685
Dr. Ruth Sarmiento, M.d, M.D
Hematology & Oncology — Payments: $3,789
Hematology & Oncology $3,789
Dr. Ha Tran, M.d, M.D
Hematology & Oncology — Payments: $2,994
Hematology & Oncology $2,994
Darion Showell, D.o, D.O
Hematology & Oncology — Payments: $2,617
Hematology & Oncology $2,617